The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Colluli SOP Project Update

21 May 2020 07:00

RNS Number : 5979N
Danakali Limited
21 May 2020
 

Announcement

Thursday, 21 May 2020

 

Colluli SOP Project Update

EPCM Phase 2 - FEED and Schedule update near completion.

 

- EPCM Phase 2 now in final stage, on budget, with completion in June 2020

- All contractor and vendor tender packages now returned allowing the evaluation stage to be completed

- Additional optimisation opportunities defined as part of the EPCM Phase 2 deliverables

Danakali Limited (ASX: DNK, LSE: DNK, Danakali, or the Company) is pleased to provide this project update of the Colluli Potash Project (Colluli or the Project), located in Eritrea, East Africa. The Project is 100% owned by the Colluli Mining Share Company (CMSC), a 50:50 joint venture between Danakali and the Eritrean National Mining Corporation (ENAMCO).

 

Even in light of COVID-19 restrictions, all EPCM Phase 2 workflows continued and all vendor and contractor packages have now been received in complete form. The receipt of these bids allows DRA Global (DRA) to finalise the tender evaluation process to provide a technically compliant and commercially favourable estimate.

 

Three key objectives set for the EPCM Phase 2 are:

- Update of the FEED Capital Estimate;

- Revision of the FEED Project Schedule; and

- Identification of key test work required to ensure full preparedness for EPCM Phase 3.

 

Completion of the identified test work items provides key data necessary to finalise process plant design development and will allow advancement into EPCM Phase 3 with clear direction.

 

A number of optimisation opportunities to improve project design will be presented at the end of EPCM Phase 2.

 

Announcement authorised for release by the Chief Executive Officer of Danakali.

 

For more information, please contact:

 

Danakali

 

Niels Wage

Chief Executive Officer

+61 8 6189 8635

Mark Riseley

Corporate Development Manager

+61 8 6189 8635

Corporate Broker - Numis Securities

UK IR/PR - Instinctif Partners

John Prior / James Black / Paul Gillam

+44 (0)20 7260 1000

Mark Garraway / Dinara Shikhametova / Sarah Hourahane

danakali@instinctif.com

+44 (0)207 457 2020

 

Visit the Company's website: www.danakali.com

Follow Danakali on LinkedIn: www.linkedin.com/company/danakali-limited

Subscribe to Danakali on YouTube: www.youtube.com/channel/UChGKN4-M4lOvPKxs9b-IJvw

About Danakali

 

Danakali Limited (ASX: DNK, LSE: DNK) (Danakali, or the Company) is an ASX- and LSE-listed potash company focused on the development of the Colluli Sulphate of Potash Project (Colluli or the Project). The Project is 100% owned by the Colluli Mining Share Company (CMSC), a 50:50 joint venture between Danakali and the Eritrean National Mining Corporation (ENAMCO).

 

The Project is located in the Danakil Depression region of Eritrea, East Africa, and is ~75km from the Red Sea coast, making it one of the most accessible potash deposits globally. Mineralisation within the Colluli resource commences at just 16m, making it the world's shallowest known potash deposit. The resource is amenable to open cut mining, which allows higher overall resource recovery to be achieved, is generally safer than underground mining, and is highly advantageous for modular growth.

 

The Company has completed a Front End Engineering Design (FEED) for the production of potassium sulphate, otherwise known as Sulphate of Potash or SOP. SOP is a chloride free, specialty fertiliser which carries a substantial price premium relative to the more common potash type; potassium chloride (or MOP). Economic resources for production of SOP are geologically scarce. The unique composition of the Colluli resource favours low energy input, high potassium yield conversion to SOP using commercially proven technology. One of the key advantages of the resource is that the salts are present in solid form (in contrast with production of SOP from brines) which reduces infrastructure costs and substantially reduces the time required to achieve full production capacity.

 

The resource is favourably positioned to supply the world's fastest growing markets. A binding take-or-pay offtake agreement has been confirmed with EuroChem Trading GmbH (EuroChem) for up to 100% (minimum 87%) of Colluli Module I SOP production.

 

Development Finance Institutions, Africa Finance Corporation (AFC) and African Export Import Bank (Afreximbank), have obtained formal credit approval to provide CMSC with US$200M in senior debt finance. The credit documentation was executed in December 2019, allowing drawdown of CMSC senior debt on satisfaction of customary conditions precedent. This represents the majority of funding required for the development and construction of the Colluli. AFC has also executed a Subscription Agreement to make a US$50M strategic equity investment in Danakali. The receipt of the first tranche of US$21.5M (A$31.8M) allowed commencement of the development.

 

Project execution has commenced and SOP production is expected during 2022. The Company's vision is to bring Colluli into production using the principles of risk management, resource utilisation and modularity, using the starting module (Module I) as a growth platform to develop the resource to its full potential.

 

 

Disclaimer

 

The information in this document is published to inform you about Danakali and its activities. Danakali has endeavoured to ensure that the information enclosed is accurate at the time of release, and that it accurately reflects the Company's intentions. To the extent permitted by law, the Company accepts no responsibility or liability for any losses or damages of any kind arising out of the use of any information contained in this document. Recipients should make their own enquiries in relation to any investment decisions.

 

No representation or warranty, express or implied, is or will be made by or on behalf of the Company, and no responsibility or liability is or will be accepted by the Company or its affiliates, as to the accuracy, completeness or verification of the information set out in this announcement, and nothing contained in this announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future. The Company and each of its affiliates accordingly disclaims, to the fullest extent permitted by law, all and any liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement or any such statement.

 

The distribution of this announcement outside the United Kingdom may be restricted by law and therefore any persons outside the United Kingdom into whose possession this announcement comes should inform themselves about and observe any such restrictions in connection with the distribution of this announcement. Any failure to comply with such restrictions may constitute a violation of the securities laws of any jurisdiction outside the United Kingdom.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSEMSIFESSEII
Date   Source Headline
9th Apr 20087:01 amRNSDisposal
19th Feb 20081:30 pmRNSIssuance of Shares
18th Feb 20084:00 pmRNSLong Term Incentive Plan
5th Feb 20081:30 pmRNS3rd Quarter Results
21st Dec 200711:10 amRNSTotal Voting Rights
18th Dec 20077:41 amRNSOTC BB - Trading begins
10th Dec 20074:40 pmRNSSecond Price Monitoring Extn
10th Dec 20074:35 pmRNSPrice Monitoring Extension
28th Nov 20075:55 pmRNSIssue of Participating Shares
28th Nov 20077:01 amRNSNASDAQ Deficiency Notice
19th Nov 20072:05 pmRNSDistribution Agreement
6th Nov 20071:30 pmRNSInterim Results
31st Oct 20073:00 pmRNSNotice of Results
5th Sep 20074:14 pmRNSResult of AGM
3rd Sep 20077:01 amRNSNasdaq Notice
21st Aug 20073:16 pmRNSIssue of Participating Shares
15th Aug 200710:38 amRNSAnnual Information Update
2nd Aug 20071:45 pmRNSExpanding product range
2nd Aug 20071:30 pmRNS1st Quarter Results
26th Jul 20071:30 pmRNSNotice of Results
25th Jul 200712:07 pmRNSHolding(s) in Company
28th Jun 20071:30 pmRNSDistribution Contract
27th Jun 20071:42 pmRNSFinal Results
26th Jun 20077:02 amRNSRefinancing Agreement
19th Jun 20071:30 pmRNSRefinancing Agreement
14th Jun 20075:02 pmRNSHolding(s) in Company
11th Jun 20073:30 pmRNSPostponement of Results
5th Jun 20071:30 pmRNSNotice of Results
15th May 200712:15 pmRNSIssue of Participating Shares
15th May 200712:07 pmRNSHolding(s) in Company
3rd May 20075:47 pmRNSTotal Voting Rights
1st May 20074:27 pmRNSHolding(s) in Company
27th Apr 20074:49 pmRNSSecond Price Monitoring Extn
27th Apr 20074:47 pmRNSPrice Monitoring Extension
18th Apr 20074:45 pmRNSPrice Monitoring Extension
26th Mar 20075:00 pmRNSIssue of Participating Shares
6th Feb 20071:30 pmRNS3rd Quarter Results
1st Feb 20077:01 amRNSRe Disposal of Danka Europe
31st Jan 200712:25 pmRNSNotice of Results
19th Jan 20075:00 pmRNSResult of EGM
21st Dec 20063:44 pmRNSTotal Voting Rights
20th Dec 20065:20 pmRNSDirectors' Shareholdings
20th Dec 20067:00 amRNSPosting of Circular
19th Dec 20062:46 pmRNSResult of AGM
7th Dec 20064:41 pmRNSSecond Price Monitoring Extn
7th Dec 20064:37 pmRNSPrice Monitoring Extension
14th Nov 20063:19 pmRNSIssue of Participating Shares
13th Nov 20066:33 pmRNSDirector/PDMR Shareholding
7th Nov 20061:30 pmRNSInterim Results
30th Oct 20066:07 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.